Mechanisms of Skin Repair by Topical Estrogen

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the way by which estrogen improves the appearance of sun damaged human skin. Accumulating evidence suggests that estrogen, taken by post menopausal women, may cause skin to look younger as a consequence of reduced wrinkles. Collagen is the most abundant protein in human skin and gives skin its strength and shape. Recent data indicate that short-term topical estrogen (17-beta estradiol) treatment increases collagen production in sun damaged skin. This study will compare the molecular and microscopic effects from topical 17-beta estradiol (E2) when applied to the skin for a short-term duration. It is anticipated that the new knowledge from this study will enable development of new ways to improve the function of aged skin.

Clinical Trial Description

The objectives of the study are to determine if topically-applied 17-beta estradiol (E2), alone or in combination with clobetasol, will produce histological and molecular effects distinguishable from vehicle in human skin. Specifically, the study will focus on regulation of collagen, elastin, and hyaluronic acid production and degradation in human skin, by steroid hormone receptors that are activated by estrogen or clobetasol. The sites to be treated will be buttock, hip, forearm, or facial skin. Subjects will receive between one to twelve vehicle (matching solution without any active ingredients), estrogen, and/or clobetasol topical applications. Skin biopsies of treated areas will be obtained at baseline and at subsequent timepoints. The study will last up to two weeks. Endpoints will include protein and mRNA levels of collagen, elastin, hyaluronic acid, and other components of skin connective tissue. In addition, we will perform cDNA microanalysis to determine estrogen/clobetasol target genes in human skin. The results from our studies will provide new knowledge regarding the molecular basis of skin aging. This new knowledge will enable development of new ways to improve the function of aged skin. ;

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Skin Wrinkling

Clinical Trial Details

NCT number	NCT00113100
Study type	Interventional
Source	University of Michigan
Contact
Status	Completed
Phase	N/A
Start date	August 2004
Completion date	June 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04606368` - Bausch Health Thermage FXL for Use on Lower Face and Submentum Area	N/A
Completed	`NCT01205061` - Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds	N/A
Completed	`NCT01205048` - Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds	N/A
Completed	`NCT02391935` - Study of Intradermal Injections of RCS-01 in Male and Female Subjects	Phase 1
Completed	`NCT01029301` - Evaluation of Safety and Efficacy of Using EndyMed Pro Skin Treatment System for Skin Wrinkle Treatment on Body Areas	N/A
Completed	`NCT04861766` - Safety and Effectiveness of STYLAGE® L for Correction of Moderate and Severe Nasolabial Folds in Chinese Adults	N/A
Completed	`NCT00114673` - A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling	N/A
Completed	`NCT00111254` - The Effects of Microdermabrasion on Skin Remodeling	N/A
Completed	`NCT00945685` - Evaluation of Safety and Efficacy of Using Imagine™ Computerized Radiofrequency System for Skin Tightening	N/A
Completed	`NCT05720000` - Use of Red Light Emitting Diode (LED) and Polydioxanone Thread in Glabellar Wrinkles	N/A
Completed	`NCT01732809` - Fields Of Effects Of Two Commercial Preparations Of Botulinum Toxin Type A At Equal Labeled Unit Doses	Phase 4
Completed	`NCT06451822` - Efficacy and Performance Evaluation of mIntense L+AS 25 mg/ml Hyaluronic Acid for the Correction of Moderate to Deep Wrinkles and Folds	N/A
Completed	`NCT00250952` - Study to Determine If the Volume Used to Dilute BOTOX Cosmetic™ for Injection Affects Its Overall Effect and Duration.	N/A
Completed	`NCT03505684` - Effect of Oral Collagen Tripeptide on Skin Moisture and Wrinkles in Adult Women	N/A
Completed	`NCT02832583` - Autologous Platelet Rich Plasma Combined to Hyaluronic Acid Obtained With Regen-Kit BCT-HA in Aesthetic Medicine	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.